Compare ICUCW & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICUCW | NUTX |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | 18 | 944 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 655.4M |
| IPO Year | 2021 | 2009 |
| Metric | ICUCW | NUTX |
|---|---|---|
| Price | $0.03 | $93.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $252.50 |
| AVG Volume (30 Days) | 30.1K | ★ 171.6K |
| Earning Date | N/A | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.93 |
| EPS | N/A | ★ 10.48 |
| Revenue | N/A | ★ $875,257,000.00 |
| Revenue This Year | N/A | $8.28 |
| Revenue Next Year | N/A | $1.96 |
| P/E Ratio | ★ N/A | $9.05 |
| Revenue Growth | N/A | ★ 82.36 |
| 52 Week Low | $0.01 | $45.88 |
| 52 Week High | $0.05 | $193.07 |
| Indicator | ICUCW | NUTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.39 | 41.24 |
| Support Level | $0.02 | $81.70 |
| Resistance Level | $0.05 | $110.29 |
| Average True Range (ATR) | 0.01 | 6.81 |
| MACD | -0.00 | 1.50 |
| Stochastic Oscillator | 78.02 | 36.56 |
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.